Recombinant DNA Technology Market By-Product(Medical, Therapeutic Agent, and Other), By Component(Expression System, Mammalian, and Other), By Application(Health And Disease, Food And Agriculture, Environment), By End-User(Biotechnology, Pharmaceutical Companies, and Other ), By Region And Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, And Forecast 2023-2032
-
3884
-
Jul 2023
-
170
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Quick Navigation
Report Overview
The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 743.6 Bn in 2022, growing at a CAGR of 5.8% during the forecast period from 2023 to 2032.
The Recombinant DNA Technology Market is an exceptionally dynamic and profitable sector within the biotechnology field. This report aims to shed light on the most recent developments, expansion, and future potential of this burgeoning market.
Recombinant DNA technology is a set of sophisticated laboratory techniques that permit the manipulation of DNA sequences and genomes. This technology gives scientists the ability to create novel genetic combinations, generate proteins with specific functions, and engineer organisms with desired characteristics. The goals of utilizing this technology are diverse, ranging from the production of new therapeutic medications to the creation of crops with the ability to resist parasites and diseases.
Recombinant DNA technology is acquiring prominence in a variety of fields, such as healthcare, agriculture, and environmental sciences. It has numerous advantages, including the production of human proteins and peptides, the generation of genetically modified crops that increase crop yields, and the production of more effective vaccines. Additionally, recombinant DNA technology has the potential to reduce the use of pesticides and herbicides in agriculture.
To improve the precision and efficacy of gene modification, research institutions, and businesses have made substantial investments in developing cutting-edge innovations such as CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and gene editing. Increasing investments in biotechnology and recombinant DNA technology have resulted in the incorporation of these techniques into a variety of commercially available products, such as pharmaceuticals, vaccines, and genetically modified crops.
Driving factors
Growth Factors for Recombinant DNA Technology
Multiple influential variables are driving the rapid expansion of the recombinant DNA technology market. The ongoing technological advancements that stimulate innovation in the field are one of the primary drivers. Recombinant DNA technology is expanding beyond its traditional domains, such as medicine and pharmaceuticals, into diverse sectors such as agriculture and environmental monitoring.
Increased Interest in Personalised Medicine and Gene Drugs
In addition, the rising demand for personalized medicines and genetically engineered medications is a major factor propelling the expansion of the recombinant DNA technology market. In many cases, these medications are more efficacious and have fewer adverse effects than their conventional counterparts, thereby increasing demand in the healthcare industry. In addition, the increasing prevalence of chronic diseases and genetic disorders stimulates research and development efforts in the field of recombinant DNA technology.
Government Initiatives and Increased Healthcare Spending
Remarkably, rising healthcare costs and government initiatives to promote biotechnology research are also driving the expansion of the recombinant DNA technology market. Governments around the world recognize the potential of this technology and are investing heavily in its research and development. This encourages innovation and encourages the development of novel treatments and therapies. The Recombinant DNA Technology Market thrives on peptides, unlocking advancements in genetic engineering and biopharmaceuticals.
Restraining Factors
Opposition to Genetic Modification
As we progress as a society, the ethical ramifications of genetic modification and the opposition to it have gained prominence. This is especially true for the use of recombinant DNA technology, which has been met with an onslaught of regulatory obstacles and government policies that present significant obstacles to the field of study.
The potential benefits of gene modification are enormous, but the perceived risks associated with it have sparked opposition from diverse sectors of society. Religious groups, for example, view it as unethical and contrary to the natural order of things, while others query the morality of playing God and tampering with human existence.
Obstacles posed by regulations and government policies
The regulatory barriers and government policies that have resulted from these concerns only serve to exacerbate the difficulties of working in this industry. Obtaining funding, approval, and the necessary permits can take years, causing substantial financial duress. Additionally, the bureaucratic red tape and protracted approval process can impede the introduction of much-needed medical advancements, thereby reducing the global efficiency of healthcare systems.
Product Analysis
Currently, the medical segment dominates the recombinant DNA technology market.
Recombinant DNA technology has been identified as one of the most significant developments in the field of biotechnology. The technology manipulates genetic material to generate superior, more efficient, and more profitable products. Medical, expression systems, health and disease, and biotechnology are just a few of the segments where the technology is used. According to a recent market research report, the medical segment presently dominates the recombinant DNA technology market, and this trend is anticipated to continue over the coming years.
Due to the increasing adoption of advanced technologies and therapies, the field of biotechnology is presently experiencing accelerated expansion. In emerging economies, the adoption rate of recombinant DNA technology has been especially high. This is primarily due to the increasing economic development in these regions. People have greater access to healthcare as the economy improves, which increases the demand for innovative medical therapies. In addition, emerging economies are experiencing substantial development in the biotechnology industry, resulting in an increase in demand for recombinant DNA technology.
Component Analysis
The Expression Systems segment dominates the recombinant DNA technology market.
Recombinant DNA technology requires expression systems, which are crucial. They facilitate the expression of various proteins, enzymes, and other substances produced by DNA manipulation. The expression systems segment currently dominates the recombinant DNA technology market. This is due to the widespread use of expression systems in applications such as research, drug discovery, gene therapy, and biomanufacturing.
Similarly to the medical segment, the expression systems segment benefits from economic growth in emerging markets. The rapid expansion of the biotechnology and pharmaceutical industries in these regions has increased the demand for expression systems. Technology advancements have made expression systems more accessible and affordable, increasing consumption and propelling segment growth.
Application Analysis
The recombinant DNA technology market is dominated by the Health and Disease segment.
Currently, the health and disease segment dominates the recombinant DNA technology market. This is due to the importance of technology in the manufacturing of therapies and remedies for a variety of diseases, including cancer, diabetes, and cardiovascular disease. The use of recombinant DNA technology has made it possible for scientists to develop novel and innovative treatments that were previously impossible.
As is the case with other segments, economic growth in emerging economies drives the adoption of the health and disease segment. The increased prevalence of chronic diseases and increased accessibility to healthcare have increased the demand for innovative therapies and treatments. The expansion of pharmaceutical companies in emerging economies has increased the demand for recombinant DNA technology.
End-User Analysis
The biotechnology segment dominates the recombinant DNA technology market.
Recombinant DNA technology is most commonly used in the biotechnology segment. This is due to the fact that recombinant DNA technology is crucial to the development of new and innovative biotechnology products. The segment consists of gene sequencing, drug discovery, and biomanufacturing companies.
As with other segments, economic growth in developing nations is propelling the adoption of recombinant DNA technology in the biotechnology sector. Demand for recombinant DNA technology has increased due to the expansion of the biotechnology industry in emerging economies.
Key Market Segments
By Product
- Medical
- Therapeutic Agent
- Human Protein
- Vaccine
- Non-medical
- Biotech Crops
- Biochemical
By Component
- Expression System
- Mammalian
- Bacteria
- Yeast
- Baculovirus / Insect
- Cloning Vector
By Application
- Health and Disease
- Food and Agriculture
- Environment
By End-User
- Biotechnology
- Pharmaceutical Companies
- Academic & Government Research Institutes
Growth Opportunity
Utilizing recombinant DNA technology to develop personalized medicines
The innovative practice of personalized medicine involves tailoring treatment plans to the specific requirements of each patient. Recombinant DNA technology has played a crucial role in the development of personalized medicine, enabling the identification of specific genetic mutations and the creation of targeted therapies for specific diseases.
Increased research and development to identify new applications for recombinant DNA technology.
As the capabilities of recombinant DNA technology continue to grow, the demand for research and development to identify new applications of the technology increases. This includes investigating new methods to use recombinant DNA technology to develop new treatments for a wide range of diseases, as well as the potential for the technology to be used in industries outside of healthcare.
Implementation of recombinant DNA technology in gene therapy
Gene therapy, which entails the delivery of therapeutic genes to specific cells in order to correct genetic defects and treat diseases, has also adopted recombinant DNA technology. Gene therapy has the potential to be highly effective in treating a wide range of genetic diseases, and recombinant DNA technology is instrumental in making this a reality.
Latest Trends
Availability of research and development funding and investment opportunities
One of the main trends in the recombinant DNA technology market is the availability of research and development funding and investment opportunities. With numerous global initiatives and funding programs supporting biotechnology research and development, companies and organizations are more likely to invest in recombinant DNA technology to create innovative products and services.
Escalating Acceptability and Awareness Of Gene Therapy And Genetic Testing
The expanding awareness and acceptance of gene therapy and genetic testing among patients and healthcare professionals also influence the recombinant DNA technology market. Gene therapy is gathering traction as a potential cure for a variety of debilitating genetic diseases, whereas genetic testing is extensively used for diagnosing diseases and predicting the likelihood of developing certain health conditions.
Increasing World Population and Demand For Enhanced Healthcare Solutions
Lastly, the increasing global population and demand for enhanced healthcare solutions are significant trends that are propelling the recombinant DNA technology market. As the world's population continues to expand, there is a growing demand for innovative healthcare solutions that can address the ever-increasing burden of diseases and healthcare costs.
Regional Analysis
North America Poised to Dominate the Recombinant DNA Technology Market
As scientific and technological advancements continue, recombinant DNA technology is becoming an increasingly vital component of DNA sequencing and biotechnology. This technology has the capacity to produce individualized DNA sequences, manipulate genes, and modify genetic information to aid in the treatment of a variety of diseases and disorders.
North America is geographically the greatest regional recombinant DNA technology market. This is due to the presence of several major market participants, the concentration of pharmaceutical and biotech firms in the region, and the favorable regulatory environment. As a result of the presence of industry leaders such as Thermo Fisher Scientific, GenScript Biotech, and Bio-Rad Laboratories, Inc., the United States is expected to lead the regional expansion.
In addition, the high prevalence of chronic diseases such as cancer and the rising demand for personalized medication are driving the growth of the recombinant DNA technology market in North America. Numerous clinical trials utilizing recombinant DNA technology to cure genetic diseases have established the region as a center for gene therapy research.
Key Regions and Countries
North America
- US
- Canada
- Mexico
Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Key Players Analysis
The multinational pharmaceutical company Novartis AG has a significant presence in the recombinant DNA technology market. The company has been developing and marketing biologics, including products based on recombinant DNA technology, for many years. The biologics portfolio of Novartis comprises Rituxan, Neulasta, and Avastin.
Biogen Inc. is another significant participant in the recombinant DNA technology market. The company specializes in the development of biological treatments for multiple sclerosis, spinal muscular atrophy, and other neurological conditions. Biogen offers products founded on recombinant DNA technology, such as Tysabri and Plegridy.
Amgen Inc., one of the world's largest biotechnology companies, has a significant presence in the recombinant DNA technology market. The company develops and commercializes biologics such as Epogen, Neupogen, and Enbrel.
GenScript, a provider of services and products for life science research, has a prominent presence in the recombinant DNA technology market. The corporation provides a variety of molecular biology-related services, including gene synthesis, cloning, and protein expression.
Top Key Players in Recombinant DNA Technology Market
- Profacgen
- Monsanto Company
- Hoffmann-La Roche AG
- Biogen Inc.
- Amgen Inc.
- Novartis AG
- Eli Lilly and Company
- Novo Nordisk A/S
- Sanofi SA
- Merck & Co., Inc.
Recent Development
- In July 2017 acquisition of Protein Sciences by Sanofi Pasteur Limited gave the company a significant boost in the influenza vaccine market. Flublok, an influenza vaccine created using recombinant DNA technology, was added as part of the acquisition.
- In 2017, the FDA approved the Mariah product by Novartis AG for the treatment of acute lymphoblastic leukemia, propelling the recombinant DNA technology market forward. This is the first gene therapy to be approved for use in the United States, and it is based on gene transfer technology.
Report Scope
Report Features Description Market Value (2022) USD 743.6 Bn Forecast Revenue (2032) USD 1288.5 Bn CAGR (2023-2032) 5.8% Base Year for Estimation 2022 Historic Period 2016-2022 Forecast Period 2023-2032 Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments Segments Covered By-product(Medical, Therapeutic Agent, Human Protein, Vaccine, Non-medical, Biotech Crops, Biochemical), By component(Expression System, Mammalian, Bacteria, Yeast, Baculovirus / Insect, Cloning Vector), By application(Health and Disease, Food and Agriculture, Environment), By end-user(Biotechnology, Pharmaceutical Companies, Academic & Government Research Institutes) Regional Analysis North America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA Competitive Landscape Profacgen, Monsanto Company, Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Novartis AG, Eli Lilly and Company, Novo Nordisk A/S, Sanofi SA, Merck & Co., Inc. Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) -
- 1. Executive Summary
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 1.4. Key Analysis
- 1.5. Key Findings by Major Segments
- 1.6. Top strategies by Major Players
- 2. Global Recombinant DNA Technology Market Overview
- 2.1. Recombinant DNA Technology Market Dynamics
- 2.1.1. Drivers
- 2.1.2. Opportunities
- 2.1.3. Restraints
- 2.1.4. Challenges
- 2.2. Macro-economic Factors
- 2.3. Regulatory Framework
- 2.4. Market Investment Feasibility Index
- 2.5. PEST Analysis
- 2.6. PORTER’S Five Force Analysis
- 2.7. Drivers & Restraints Impact Analysis
- 2.8. Industry Chain Analysis
- 2.9. Cost Structure Analysis
- 2.10. Marketing Strategy
- 2.11. Russia-Ukraine War Impact Analysis
- 2.12. Opportunity Map Analysis
- 2.13. Market Competition Scenario Analysis
- 2.14. Product Life Cycle Analysis
- 2.15. Opportunity Orbits
- 2.16. Manufacturer Intensity Map
- 2.17. Major Companies sales by Value & Volume
- 2.1. Recombinant DNA Technology Market Dynamics
- 3. Global Recombinant DNA Technology Market Analysis, Opportunity and Forecast, 2016-2032
- 3.1. Global Recombinant DNA Technology Market Analysis, 2016-2021
- 3.2. Global Recombinant DNA Technology Market Opportunity and Forecast, 2023-2032
- 3.3. Global Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By Product , 2016-2032
- 3.3.1. Global Recombinant DNA Technology Market Analysis by By Product : Introduction
- 3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product , 2016-2032
- 3.3.3. Medical
- 3.3.4. Therapeutic Agent
- 3.3.5. Human Protein
- 3.3.6. Vaccine
- 3.3.7. Non-medical
- 3.3.8. Biotech Crops
- 3.3.9. Biochemical
- 3.4. Global Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By component, 2016-2032
- 3.4.1. Global Recombinant DNA Technology Market Analysis by By component: Introduction
- 3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By component, 2016-2032
- 3.4.3. Expression System
- 3.4.4. Mammalian
- 3.4.5. Bacteria
- 3.4.6. Yeast
- 3.4.7. Baculovirus / Insect
- 3.4.8. Cloning Vector
- 3.5. Global Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By application, 2016-2032
- 3.5.1. Global Recombinant DNA Technology Market Analysis by By application: Introduction
- 3.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By application, 2016-2032
- 3.5.3. Health and Disease
- 3.5.4. Food and Agriculture
- 3.5.5. Environment
- 3.6. Global Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By end-user, 2016-2032
- 3.6.1. Global Recombinant DNA Technology Market Analysis by By end-user: Introduction
- 3.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By end-user, 2016-2032
- 3.6.3. Biotechnology
- 3.6.4. Pharmaceutical Companies
- 3.6.5. Academic & Government Research Institutes
- 4. North America Recombinant DNA Technology Market Analysis, Opportunity and Forecast, 2016-2032
- 4.1. North America Recombinant DNA Technology Market Analysis, 2016-2021
- 4.2. North America Recombinant DNA Technology Market Opportunity and Forecast, 2023-2032
- 4.3. North America Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By Product , 2016-2032
- 4.3.1. North America Recombinant DNA Technology Market Analysis by By Product : Introduction
- 4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product , 2016-2032
- 4.3.3. Medical
- 4.3.4. Therapeutic Agent
- 4.3.5. Human Protein
- 4.3.6. Vaccine
- 4.3.7. Non-medical
- 4.3.8. Biotech Crops
- 4.3.9. Biochemical
- 4.4. North America Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By component, 2016-2032
- 4.4.1. North America Recombinant DNA Technology Market Analysis by By component: Introduction
- 4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By component, 2016-2032
- 4.4.3. Expression System
- 4.4.4. Mammalian
- 4.4.5. Bacteria
- 4.4.6. Yeast
- 4.4.7. Baculovirus / Insect
- 4.4.8. Cloning Vector
- 4.5. North America Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By application, 2016-2032
- 4.5.1. North America Recombinant DNA Technology Market Analysis by By application: Introduction
- 4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By application, 2016-2032
- 4.5.3. Health and Disease
- 4.5.4. Food and Agriculture
- 4.5.5. Environment
- 4.6. North America Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By end-user, 2016-2032
- 4.6.1. North America Recombinant DNA Technology Market Analysis by By end-user: Introduction
- 4.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By end-user, 2016-2032
- 4.6.3. Biotechnology
- 4.6.4. Pharmaceutical Companies
- 4.6.5. Academic & Government Research Institutes
- 4.7. North America Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 4.7.1. North America Recombinant DNA Technology Market Analysis by Country : Introduction
- 4.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 4.7.2.1. The US
- 4.7.2.2. Canada
- 4.7.2.3. Mexico
- 5. Western Europe Recombinant DNA Technology Market Analysis, Opportunity and Forecast, 2016-2032
- 5.1. Western Europe Recombinant DNA Technology Market Analysis, 2016-2021
- 5.2. Western Europe Recombinant DNA Technology Market Opportunity and Forecast, 2023-2032
- 5.3. Western Europe Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By Product , 2016-2032
- 5.3.1. Western Europe Recombinant DNA Technology Market Analysis by By Product : Introduction
- 5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product , 2016-2032
- 5.3.3. Medical
- 5.3.4. Therapeutic Agent
- 5.3.5. Human Protein
- 5.3.6. Vaccine
- 5.3.7. Non-medical
- 5.3.8. Biotech Crops
- 5.3.9. Biochemical
- 5.4. Western Europe Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By component, 2016-2032
- 5.4.1. Western Europe Recombinant DNA Technology Market Analysis by By component: Introduction
- 5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By component, 2016-2032
- 5.4.3. Expression System
- 5.4.4. Mammalian
- 5.4.5. Bacteria
- 5.4.6. Yeast
- 5.4.7. Baculovirus / Insect
- 5.4.8. Cloning Vector
- 5.5. Western Europe Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By application, 2016-2032
- 5.5.1. Western Europe Recombinant DNA Technology Market Analysis by By application: Introduction
- 5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By application, 2016-2032
- 5.5.3. Health and Disease
- 5.5.4. Food and Agriculture
- 5.5.5. Environment
- 5.6. Western Europe Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By end-user, 2016-2032
- 5.6.1. Western Europe Recombinant DNA Technology Market Analysis by By end-user: Introduction
- 5.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By end-user, 2016-2032
- 5.6.3. Biotechnology
- 5.6.4. Pharmaceutical Companies
- 5.6.5. Academic & Government Research Institutes
- 5.7. Western Europe Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 5.7.1. Western Europe Recombinant DNA Technology Market Analysis by Country : Introduction
- 5.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 5.7.2.1. Germany
- 5.7.2.2. France
- 5.7.2.3. The UK
- 5.7.2.4. Spain
- 5.7.2.5. Italy
- 5.7.2.6. Portugal
- 5.7.2.7. Ireland
- 5.7.2.8. Austria
- 5.7.2.9. Switzerland
- 5.7.2.10. Benelux
- 5.7.2.11. Nordic
- 5.7.2.12. Rest of Western Europe
- 6. Eastern Europe Recombinant DNA Technology Market Analysis, Opportunity and Forecast, 2016-2032
- 6.1. Eastern Europe Recombinant DNA Technology Market Analysis, 2016-2021
- 6.2. Eastern Europe Recombinant DNA Technology Market Opportunity and Forecast, 2023-2032
- 6.3. Eastern Europe Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By Product , 2016-2032
- 6.3.1. Eastern Europe Recombinant DNA Technology Market Analysis by By Product : Introduction
- 6.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product , 2016-2032
- 6.3.3. Medical
- 6.3.4. Therapeutic Agent
- 6.3.5. Human Protein
- 6.3.6. Vaccine
- 6.3.7. Non-medical
- 6.3.8. Biotech Crops
- 6.3.9. Biochemical
- 6.4. Eastern Europe Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By component, 2016-2032
- 6.4.1. Eastern Europe Recombinant DNA Technology Market Analysis by By component: Introduction
- 6.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By component, 2016-2032
- 6.4.3. Expression System
- 6.4.4. Mammalian
- 6.4.5. Bacteria
- 6.4.6. Yeast
- 6.4.7. Baculovirus / Insect
- 6.4.8. Cloning Vector
- 6.5. Eastern Europe Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By application, 2016-2032
- 6.5.1. Eastern Europe Recombinant DNA Technology Market Analysis by By application: Introduction
- 6.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By application, 2016-2032
- 6.5.3. Health and Disease
- 6.5.4. Food and Agriculture
- 6.5.5. Environment
- 6.6. Eastern Europe Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By end-user, 2016-2032
- 6.6.1. Eastern Europe Recombinant DNA Technology Market Analysis by By end-user: Introduction
- 6.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By end-user, 2016-2032
- 6.6.3. Biotechnology
- 6.6.4. Pharmaceutical Companies
- 6.6.5. Academic & Government Research Institutes
- 6.7. Eastern Europe Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 6.7.1. Eastern Europe Recombinant DNA Technology Market Analysis by Country : Introduction
- 6.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 6.7.2.1. Russia
- 6.7.2.2. Poland
- 6.7.2.3. The Czech Republic
- 6.7.2.4. Greece
- 6.7.2.5. Rest of Eastern Europe
- 7. APAC Recombinant DNA Technology Market Analysis, Opportunity and Forecast, 2016-2032
- 7.1. APAC Recombinant DNA Technology Market Analysis, 2016-2021
- 7.2. APAC Recombinant DNA Technology Market Opportunity and Forecast, 2023-2032
- 7.3. APAC Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By Product , 2016-2032
- 7.3.1. APAC Recombinant DNA Technology Market Analysis by By Product : Introduction
- 7.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product , 2016-2032
- 7.3.3. Medical
- 7.3.4. Therapeutic Agent
- 7.3.5. Human Protein
- 7.3.6. Vaccine
- 7.3.7. Non-medical
- 7.3.8. Biotech Crops
- 7.3.9. Biochemical
- 7.4. APAC Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By component, 2016-2032
- 7.4.1. APAC Recombinant DNA Technology Market Analysis by By component: Introduction
- 7.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By component, 2016-2032
- 7.4.3. Expression System
- 7.4.4. Mammalian
- 7.4.5. Bacteria
- 7.4.6. Yeast
- 7.4.7. Baculovirus / Insect
- 7.4.8. Cloning Vector
- 7.5. APAC Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By application, 2016-2032
- 7.5.1. APAC Recombinant DNA Technology Market Analysis by By application: Introduction
- 7.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By application, 2016-2032
- 7.5.3. Health and Disease
- 7.5.4. Food and Agriculture
- 7.5.5. Environment
- 7.6. APAC Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By end-user, 2016-2032
- 7.6.1. APAC Recombinant DNA Technology Market Analysis by By end-user: Introduction
- 7.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By end-user, 2016-2032
- 7.6.3. Biotechnology
- 7.6.4. Pharmaceutical Companies
- 7.6.5. Academic & Government Research Institutes
- 7.7. APAC Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 7.7.1. APAC Recombinant DNA Technology Market Analysis by Country : Introduction
- 7.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 7.7.2.1. China
- 7.7.2.2. Japan
- 7.7.2.3. South Korea
- 7.7.2.4. India
- 7.7.2.5. Australia & New Zeland
- 7.7.2.6. Indonesia
- 7.7.2.7. Malaysia
- 7.7.2.8. Philippines
- 7.7.2.9. Singapore
- 7.7.2.10. Thailand
- 7.7.2.11. Vietnam
- 7.7.2.12. Rest of APAC
- 8. Latin America Recombinant DNA Technology Market Analysis, Opportunity and Forecast, 2016-2032
- 8.1. Latin America Recombinant DNA Technology Market Analysis, 2016-2021
- 8.2. Latin America Recombinant DNA Technology Market Opportunity and Forecast, 2023-2032
- 8.3. Latin America Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By Product , 2016-2032
- 8.3.1. Latin America Recombinant DNA Technology Market Analysis by By Product : Introduction
- 8.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product , 2016-2032
- 8.3.3. Medical
- 8.3.4. Therapeutic Agent
- 8.3.5. Human Protein
- 8.3.6. Vaccine
- 8.3.7. Non-medical
- 8.3.8. Biotech Crops
- 8.3.9. Biochemical
- 8.4. Latin America Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By component, 2016-2032
- 8.4.1. Latin America Recombinant DNA Technology Market Analysis by By component: Introduction
- 8.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By component, 2016-2032
- 8.4.3. Expression System
- 8.4.4. Mammalian
- 8.4.5. Bacteria
- 8.4.6. Yeast
- 8.4.7. Baculovirus / Insect
- 8.4.8. Cloning Vector
- 8.5. Latin America Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By application, 2016-2032
- 8.5.1. Latin America Recombinant DNA Technology Market Analysis by By application: Introduction
- 8.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By application, 2016-2032
- 8.5.3. Health and Disease
- 8.5.4. Food and Agriculture
- 8.5.5. Environment
- 8.6. Latin America Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By end-user, 2016-2032
- 8.6.1. Latin America Recombinant DNA Technology Market Analysis by By end-user: Introduction
- 8.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By end-user, 2016-2032
- 8.6.3. Biotechnology
- 8.6.4. Pharmaceutical Companies
- 8.6.5. Academic & Government Research Institutes
- 8.7. Latin America Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 8.7.1. Latin America Recombinant DNA Technology Market Analysis by Country : Introduction
- 8.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 8.7.2.1. Brazil
- 8.7.2.2. Colombia
- 8.7.2.3. Chile
- 8.7.2.4. Argentina
- 8.7.2.5. Costa Rica
- 8.7.2.6. Rest of Latin America
- 9. Middle East & Africa Recombinant DNA Technology Market Analysis, Opportunity and Forecast, 2016-2032
- 9.1. Middle East & Africa Recombinant DNA Technology Market Analysis, 2016-2021
- 9.2. Middle East & Africa Recombinant DNA Technology Market Opportunity and Forecast, 2023-2032
- 9.3. Middle East & Africa Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By Product , 2016-2032
- 9.3.1. Middle East & Africa Recombinant DNA Technology Market Analysis by By Product : Introduction
- 9.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product , 2016-2032
- 9.3.3. Medical
- 9.3.4. Therapeutic Agent
- 9.3.5. Human Protein
- 9.3.6. Vaccine
- 9.3.7. Non-medical
- 9.3.8. Biotech Crops
- 9.3.9. Biochemical
- 9.4. Middle East & Africa Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By component, 2016-2032
- 9.4.1. Middle East & Africa Recombinant DNA Technology Market Analysis by By component: Introduction
- 9.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By component, 2016-2032
- 9.4.3. Expression System
- 9.4.4. Mammalian
- 9.4.5. Bacteria
- 9.4.6. Yeast
- 9.4.7. Baculovirus / Insect
- 9.4.8. Cloning Vector
- 9.5. Middle East & Africa Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By application, 2016-2032
- 9.5.1. Middle East & Africa Recombinant DNA Technology Market Analysis by By application: Introduction
- 9.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By application, 2016-2032
- 9.5.3. Health and Disease
- 9.5.4. Food and Agriculture
- 9.5.5. Environment
- 9.6. Middle East & Africa Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By By end-user, 2016-2032
- 9.6.1. Middle East & Africa Recombinant DNA Technology Market Analysis by By end-user: Introduction
- 9.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By end-user, 2016-2032
- 9.6.3. Biotechnology
- 9.6.4. Pharmaceutical Companies
- 9.6.5. Academic & Government Research Institutes
- 9.7. Middle East & Africa Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 9.7.1. Middle East & Africa Recombinant DNA Technology Market Analysis by Country : Introduction
- 9.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 9.7.2.1. Algeria
- 9.7.2.2. Egypt
- 9.7.2.3. Israel
- 9.7.2.4. Kuwait
- 9.7.2.5. Nigeria
- 9.7.2.6. Saudi Arabia
- 9.7.2.7. South Africa
- 9.7.2.8. Turkey
- 9.7.2.9. The UAE
- 9.7.2.10. Rest of MEA
- 10. Global Recombinant DNA Technology Market Analysis, Opportunity and Forecast, By Region , 2016-2032
- 10.1. Global Recombinant DNA Technology Market Analysis by Region : Introduction
- 10.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region , 2016-2032
- 10.2.1. North America
- 10.2.2. Western Europe
- 10.2.3. Eastern Europe
- 10.2.4. APAC
- 10.2.5. Latin America
- 10.2.6. Middle East & Africa
- 11. Global Recombinant DNA Technology Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 11.1. Market Share Analysis
- 11.2. Company Profiles
- 11.3. Profacgen
- 11.3.1. Company Overview
- 11.3.2. Financial Highlights
- 11.3.3. Product Portfolio
- 11.3.4. SWOT Analysis
- 11.3.5. Key Strategies and Developments
- 11.4. Monsanto Company
- 11.4.1. Company Overview
- 11.4.2. Financial Highlights
- 11.4.3. Product Portfolio
- 11.4.4. SWOT Analysis
- 11.4.5. Key Strategies and Developments
- 11.5. Hoffmann-La Roche AG
- 11.5.1. Company Overview
- 11.5.2. Financial Highlights
- 11.5.3. Product Portfolio
- 11.5.4. SWOT Analysis
- 11.5.5. Key Strategies and Developments
- 11.6. Biogen Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Highlights
- 11.6.3. Product Portfolio
- 11.6.4. SWOT Analysis
- 11.6.5. Key Strategies and Developments
- 11.7. Amgen Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Highlights
- 11.7.3. Product Portfolio
- 11.7.4. SWOT Analysis
- 11.7.5. Key Strategies and Developments
- 11.8. Novartis AG
- 11.8.1. Company Overview
- 11.8.2. Financial Highlights
- 11.8.3. Product Portfolio
- 11.8.4. SWOT Analysis
- 11.8.5. Key Strategies and Developments
- 11.9. Eli Lilly and Company
- 11.9.1. Company Overview
- 11.9.2. Financial Highlights
- 11.9.3. Product Portfolio
- 11.9.4. SWOT Analysis
- 11.9.5. Key Strategies and Developments
- 11.10. Novo Nordisk A/S
- 11.10.1. Company Overview
- 11.10.2. Financial Highlights
- 11.10.3. Product Portfolio
- 11.10.4. SWOT Analysis
- 11.10.5. Key Strategies and Developments
- 11.11. Sanofi SA
- 11.11.1. Company Overview
- 11.11.2. Financial Highlights
- 11.11.3. Product Portfolio
- 11.11.4. SWOT Analysis
- 11.11.5. Key Strategies and Developments
- 11.12. Merck & Co., Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Highlights
- 11.12.3. Product Portfolio
- 11.12.4. SWOT Analysis
- 11.12.5. Key Strategies and Developments
- 12. Assumptions and Acronyms
- 13. Research Methodology
- 14. Contact
- List of Figures
- Figure 1: Global Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By Product in 2022
- Figure 2: Global Recombinant DNA Technology Market Attractiveness Analysis by By Product , 2016-2032
- Figure 3: Global Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By componentin 2022
- Figure 4: Global Recombinant DNA Technology Market Attractiveness Analysis by By component, 2016-2032
- Figure 5: Global Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By applicationin 2022
- Figure 6: Global Recombinant DNA Technology Market Attractiveness Analysis by By application, 2016-2032
- Figure 7: Global Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By end-userin 2022
- Figure 8: Global Recombinant DNA Technology Market Attractiveness Analysis by By end-user, 2016-2032
- Figure 9: Global Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by Region in 2022
- Figure 10: Global Recombinant DNA Technology Market Attractiveness Analysis by Region, 2016-2032
- Figure 11: Global Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Figure 12: Global Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Figure 13: Global Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 14: Global Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Figure 15: Global Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Figure 16: Global Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Figure 17: Global Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
- Figure 18: Global Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 19: Global Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Figure 20: Global Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Figure 21: Global Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Figure 22: Global Recombinant DNA Technology Market Share Comparison by Region (2016-2032)
- Figure 23: Global Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Figure 24: Global Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Figure 25: Global Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Figure 26: Global Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- Figure 27: North America Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By Product in 2022
- Figure 28: North America Recombinant DNA Technology Market Attractiveness Analysis by By Product , 2016-2032
- Figure 29: North America Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By componentin 2022
- Figure 30: North America Recombinant DNA Technology Market Attractiveness Analysis by By component, 2016-2032
- Figure 31: North America Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By applicationin 2022
- Figure 32: North America Recombinant DNA Technology Market Attractiveness Analysis by By application, 2016-2032
- Figure 33: North America Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By end-userin 2022
- Figure 34: North America Recombinant DNA Technology Market Attractiveness Analysis by By end-user, 2016-2032
- Figure 35: North America Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 36: North America Recombinant DNA Technology Market Attractiveness Analysis by Country, 2016-2032
- Figure 37: North America Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Figure 38: North America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 39: North America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 40: North America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Figure 41: North America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Figure 42: North America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Figure 43: North America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 44: North America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 45: North America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Figure 46: North America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Figure 47: North America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Figure 48: North America Recombinant DNA Technology Market Share Comparison by Country (2016-2032)
- Figure 49: North America Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Figure 50: North America Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Figure 51: North America Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Figure 52: North America Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- Figure 53: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By Product in 2022
- Figure 54: Western Europe Recombinant DNA Technology Market Attractiveness Analysis by By Product , 2016-2032
- Figure 55: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By componentin 2022
- Figure 56: Western Europe Recombinant DNA Technology Market Attractiveness Analysis by By component, 2016-2032
- Figure 57: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By applicationin 2022
- Figure 58: Western Europe Recombinant DNA Technology Market Attractiveness Analysis by By application, 2016-2032
- Figure 59: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By end-userin 2022
- Figure 60: Western Europe Recombinant DNA Technology Market Attractiveness Analysis by By end-user, 2016-2032
- Figure 61: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 62: Western Europe Recombinant DNA Technology Market Attractiveness Analysis by Country, 2016-2032
- Figure 63: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Figure 64: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 65: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 66: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Figure 67: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Figure 68: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Figure 69: Western Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 70: Western Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 71: Western Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Figure 72: Western Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Figure 73: Western Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Figure 74: Western Europe Recombinant DNA Technology Market Share Comparison by Country (2016-2032)
- Figure 75: Western Europe Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Figure 76: Western Europe Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Figure 77: Western Europe Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Figure 78: Western Europe Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- Figure 79: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By Product in 2022
- Figure 80: Eastern Europe Recombinant DNA Technology Market Attractiveness Analysis by By Product , 2016-2032
- Figure 81: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By componentin 2022
- Figure 82: Eastern Europe Recombinant DNA Technology Market Attractiveness Analysis by By component, 2016-2032
- Figure 83: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By applicationin 2022
- Figure 84: Eastern Europe Recombinant DNA Technology Market Attractiveness Analysis by By application, 2016-2032
- Figure 85: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By end-userin 2022
- Figure 86: Eastern Europe Recombinant DNA Technology Market Attractiveness Analysis by By end-user, 2016-2032
- Figure 87: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 88: Eastern Europe Recombinant DNA Technology Market Attractiveness Analysis by Country, 2016-2032
- Figure 89: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Figure 90: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 91: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 92: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Figure 93: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Figure 94: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Figure 95: Eastern Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 96: Eastern Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 97: Eastern Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Figure 98: Eastern Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Figure 99: Eastern Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Figure 100: Eastern Europe Recombinant DNA Technology Market Share Comparison by Country (2016-2032)
- Figure 101: Eastern Europe Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Figure 102: Eastern Europe Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Figure 103: Eastern Europe Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Figure 104: Eastern Europe Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- Figure 105: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By Product in 2022
- Figure 106: APAC Recombinant DNA Technology Market Attractiveness Analysis by By Product , 2016-2032
- Figure 107: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By componentin 2022
- Figure 108: APAC Recombinant DNA Technology Market Attractiveness Analysis by By component, 2016-2032
- Figure 109: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By applicationin 2022
- Figure 110: APAC Recombinant DNA Technology Market Attractiveness Analysis by By application, 2016-2032
- Figure 111: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By end-userin 2022
- Figure 112: APAC Recombinant DNA Technology Market Attractiveness Analysis by By end-user, 2016-2032
- Figure 113: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 114: APAC Recombinant DNA Technology Market Attractiveness Analysis by Country, 2016-2032
- Figure 115: APAC Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Figure 116: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 117: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 118: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Figure 119: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Figure 120: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Figure 121: APAC Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 122: APAC Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 123: APAC Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Figure 124: APAC Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Figure 125: APAC Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Figure 126: APAC Recombinant DNA Technology Market Share Comparison by Country (2016-2032)
- Figure 127: APAC Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Figure 128: APAC Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Figure 129: APAC Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Figure 130: APAC Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- Figure 131: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By Product in 2022
- Figure 132: Latin America Recombinant DNA Technology Market Attractiveness Analysis by By Product , 2016-2032
- Figure 133: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By componentin 2022
- Figure 134: Latin America Recombinant DNA Technology Market Attractiveness Analysis by By component, 2016-2032
- Figure 135: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By applicationin 2022
- Figure 136: Latin America Recombinant DNA Technology Market Attractiveness Analysis by By application, 2016-2032
- Figure 137: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By end-userin 2022
- Figure 138: Latin America Recombinant DNA Technology Market Attractiveness Analysis by By end-user, 2016-2032
- Figure 139: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 140: Latin America Recombinant DNA Technology Market Attractiveness Analysis by Country, 2016-2032
- Figure 141: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Figure 142: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 143: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 144: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Figure 145: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Figure 146: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Figure 147: Latin America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 148: Latin America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 149: Latin America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Figure 150: Latin America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Figure 151: Latin America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Figure 152: Latin America Recombinant DNA Technology Market Share Comparison by Country (2016-2032)
- Figure 153: Latin America Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Figure 154: Latin America Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Figure 155: Latin America Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Figure 156: Latin America Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- Figure 157: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By Product in 2022
- Figure 158: Middle East & Africa Recombinant DNA Technology Market Attractiveness Analysis by By Product , 2016-2032
- Figure 159: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By componentin 2022
- Figure 160: Middle East & Africa Recombinant DNA Technology Market Attractiveness Analysis by By component, 2016-2032
- Figure 161: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By applicationin 2022
- Figure 162: Middle East & Africa Recombinant DNA Technology Market Attractiveness Analysis by By application, 2016-2032
- Figure 163: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by By end-userin 2022
- Figure 164: Middle East & Africa Recombinant DNA Technology Market Attractiveness Analysis by By end-user, 2016-2032
- Figure 165: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 166: Middle East & Africa Recombinant DNA Technology Market Attractiveness Analysis by Country, 2016-2032
- Figure 167: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Figure 168: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 169: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 170: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Figure 171: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Figure 172: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Figure 173: Middle East & Africa Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 174: Middle East & Africa Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 175: Middle East & Africa Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Figure 176: Middle East & Africa Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Figure 177: Middle East & Africa Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Figure 178: Middle East & Africa Recombinant DNA Technology Market Share Comparison by Country (2016-2032)
- Figure 179: Middle East & Africa Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Figure 180: Middle East & Africa Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Figure 181: Middle East & Africa Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Figure 182: Middle East & Africa Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- List of Tables
- Table 1: Global Recombinant DNA Technology Market Comparison by By Product (2016-2032)
- Table 2: Global Recombinant DNA Technology Market Comparison by By component (2016-2032)
- Table 3: Global Recombinant DNA Technology Market Comparison by By application (2016-2032)
- Table 4: Global Recombinant DNA Technology Market Comparison by By end-user (2016-2032)
- Table 5: Global Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Table 6: Global Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Table 7: Global Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Table 8: Global Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 9: Global Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Table 10: Global Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Table 11: Global Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Table 12: Global Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
- Table 13: Global Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 14: Global Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Table 15: Global Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Table 16: Global Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Table 17: Global Recombinant DNA Technology Market Share Comparison by Region (2016-2032)
- Table 18: Global Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Table 19: Global Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Table 20: Global Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Table 21: Global Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- Table 22: North America Recombinant DNA Technology Market Comparison by By component (2016-2032)
- Table 23: North America Recombinant DNA Technology Market Comparison by By application (2016-2032)
- Table 24: North America Recombinant DNA Technology Market Comparison by By end-user (2016-2032)
- Table 25: North America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 26: North America Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Table 27: North America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 28: North America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 29: North America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Table 30: North America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Table 31: North America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Table 32: North America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 33: North America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 34: North America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Table 35: North America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Table 36: North America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Table 37: North America Recombinant DNA Technology Market Share Comparison by Country (2016-2032)
- Table 38: North America Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Table 39: North America Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Table 40: North America Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Table 41: North America Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- Table 42: Western Europe Recombinant DNA Technology Market Comparison by By Product (2016-2032)
- Table 43: Western Europe Recombinant DNA Technology Market Comparison by By component (2016-2032)
- Table 44: Western Europe Recombinant DNA Technology Market Comparison by By application (2016-2032)
- Table 45: Western Europe Recombinant DNA Technology Market Comparison by By end-user (2016-2032)
- Table 46: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 47: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Table 48: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 49: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 50: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Table 51: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Table 52: Western Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Table 53: Western Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 54: Western Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 55: Western Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Table 56: Western Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Table 57: Western Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Table 58: Western Europe Recombinant DNA Technology Market Share Comparison by Country (2016-2032)
- Table 59: Western Europe Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Table 60: Western Europe Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Table 61: Western Europe Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Table 62: Western Europe Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- Table 63: Eastern Europe Recombinant DNA Technology Market Comparison by By Product (2016-2032)
- Table 64: Eastern Europe Recombinant DNA Technology Market Comparison by By component (2016-2032)
- Table 65: Eastern Europe Recombinant DNA Technology Market Comparison by By application (2016-2032)
- Table 66: Eastern Europe Recombinant DNA Technology Market Comparison by By end-user (2016-2032)
- Table 67: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 68: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Table 69: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 70: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 71: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Table 72: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Table 73: Eastern Europe Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Table 74: Eastern Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 75: Eastern Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 76: Eastern Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Table 77: Eastern Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Table 78: Eastern Europe Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Table 79: Eastern Europe Recombinant DNA Technology Market Share Comparison by Country (2016-2032)
- Table 80: Eastern Europe Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Table 81: Eastern Europe Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Table 82: Eastern Europe Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Table 83: Eastern Europe Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- Table 84: APAC Recombinant DNA Technology Market Comparison by By Product (2016-2032)
- Table 85: APAC Recombinant DNA Technology Market Comparison by By component (2016-2032)
- Table 86: APAC Recombinant DNA Technology Market Comparison by By application (2016-2032)
- Table 87: APAC Recombinant DNA Technology Market Comparison by By end-user (2016-2032)
- Table 88: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 89: APAC Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Table 90: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 91: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 92: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Table 93: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Table 94: APAC Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Table 95: APAC Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 96: APAC Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 97: APAC Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Table 98: APAC Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Table 99: APAC Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Table 100: APAC Recombinant DNA Technology Market Share Comparison by Country (2016-2032)
- Table 101: APAC Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Table 102: APAC Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Table 103: APAC Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Table 104: APAC Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- Table 105: Latin America Recombinant DNA Technology Market Comparison by By Product (2016-2032)
- Table 106: Latin America Recombinant DNA Technology Market Comparison by By component (2016-2032)
- Table 107: Latin America Recombinant DNA Technology Market Comparison by By application (2016-2032)
- Table 108: Latin America Recombinant DNA Technology Market Comparison by By end-user (2016-2032)
- Table 109: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 110: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Table 111: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 112: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 113: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Table 114: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Table 115: Latin America Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Table 116: Latin America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 117: Latin America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 118: Latin America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Table 119: Latin America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Table 120: Latin America Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Table 121: Latin America Recombinant DNA Technology Market Share Comparison by Country (2016-2032)
- Table 122: Latin America Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Table 123: Latin America Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Table 124: Latin America Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Table 125: Latin America Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- Table 126: Middle East & Africa Recombinant DNA Technology Market Comparison by By Product (2016-2032)
- Table 127: Middle East & Africa Recombinant DNA Technology Market Comparison by By component (2016-2032)
- Table 128: Middle East & Africa Recombinant DNA Technology Market Comparison by By application (2016-2032)
- Table 129: Middle East & Africa Recombinant DNA Technology Market Comparison by By end-user (2016-2032)
- Table 130: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 131: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) (2016-2032)
- Table 132: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 133: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 134: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By component (2016-2032)
- Table 135: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By application (2016-2032)
- Table 136: Middle East & Africa Recombinant DNA Technology Market Revenue (US$ Mn) Comparison by By end-user (2016-2032)
- Table 137: Middle East & Africa Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 138: Middle East & Africa Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 139: Middle East & Africa Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By component (2016-2032)
- Table 140: Middle East & Africa Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By application (2016-2032)
- Table 141: Middle East & Africa Recombinant DNA Technology Market Y-o-Y Growth Rate Comparison by By end-user (2016-2032)
- Table 142: Middle East & Africa Recombinant DNA Technology Market Share Comparison by Country (2016-2032)
- Table 143: Middle East & Africa Recombinant DNA Technology Market Share Comparison by By Product (2016-2032)
- Table 144: Middle East & Africa Recombinant DNA Technology Market Share Comparison by By component (2016-2032)
- Table 145: Middle East & Africa Recombinant DNA Technology Market Share Comparison by By application (2016-2032)
- Table 146: Middle East & Africa Recombinant DNA Technology Market Share Comparison by By end-user (2016-2032)
- 1. Executive Summary
-
- Profacgen
- Monsanto Company
- Hoffmann-La Roche AG
- Biogen Inc.
- Amgen Inc.
- Novartis AG
- Eli Lilly and Company
- Novo Nordisk A/S
- Sanofi SA
- Merck & Co., Inc.
Our Clients
View Our Licence Options
